Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Hybrid Revascularization
100%
Percutaneous Coronary Intervention
100%
Hybrid Coronary Revascularization
100%
Coronary Artery Disease
50%
Pivotal Trial
50%
Coronary Artery Bypass Grafting
30%
Data Coordinating Center
30%
Clinical Centers
30%
Clinical Trials
20%
Multivessel Coronary Artery Disease
20%
Drug-eluting Stent
20%
Grant Applications
20%
Cardiovascular Medicine
20%
Multivessel Percutaneous Coronary Intervention
20%
Planning Phase
10%
Stenosed Coronary Artery
10%
Degree of Innovation
10%
Validated Approach
10%
Organized Activities
10%
Industrial Companies
10%
Medical Therapy
10%
Patient Demographics
10%
New Therapies
10%
Treatment Strategy
10%
Healthcare Resources
10%
Treatment philosophy
10%
Economic Impact
10%
Coronary Revascularization
10%
Conventional Coronary Artery Bypass Grafting
10%
NHLBI
10%
Intervention Therapy
10%
Revascularization
10%
Health Systems
10%
Increasing Prevalence
10%
Patient Engagement
10%
Observational Data
10%
Clinical Research
10%
Cost-effectiveness
10%
Prolonged Recovery
10%
Randomized Trial
10%
Time Characteristics
10%
Cardiothoracic Surgical Trials Network
10%
Coronary Patients
10%
Healthcare Utilization
10%
Cardiologists
10%
Recovery Time
10%
Successful Implementation
10%
Trial Design
10%
Treatment Decisions
10%
Payers
10%
Inpatient Treatment
10%
Optimal Technique
10%
Alternative Treatment Methods
10%
Heart Center
10%
Disease Therapeutics
10%
Lack of Evidence
10%
Impact on Public Health
10%
Cardiac Surgeons
10%
Diseased Population
10%
Trauma Recovery
10%
Healthcare Providers
10%
Medicine and Dentistry
Revascularization
100%
Percutaneous Coronary Intervention
100%
Heart Muscle Revascularization
100%
Coronary Artery Disease
72%
Coronary Artery Bypass Graft
36%
Health Care
18%
Clinical Trial
18%
Drug-Eluting Stent
18%
Observational Study
18%
Cardiovascular Medicine
18%
Health Care Cost
18%
Clinical Research
9%
Patient Population
9%
Cardiothoracics
9%
Coronary Artery
9%
Public Health
9%
Surgeon
9%
Prevalence
9%
Clinician
9%
Diseases
9%
Treatment Option
9%
Health Care Personnel
9%